Intensity Therapeutics, Inc.

61 Wilton Road, 3rd Floor

Westport, CT 068809

 

February 9, 2023

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

  RE: Intensity Therapeutics, Inc. (CIK 0001567264)
    Registration Statement No. 333-260565 on Form S-1 (the “Registration Statement”)

 

Ladies and Gentlemen:

 

Intensity Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on February 13, 2023 at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.

 

The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will & Emery LLP, by calling Daniel L. Woodard at (212) 547-5553. The Company hereby authorizes Mr. Woodard to orally modify or withdraw this request for acceleration.  

 

  Very truly yours,
   
  INTENSITY THERAPEUTICS, INC.
   
  By: /s/ Lewis H. Bender 
   

Lewis H. Bender

Chief Executive Officer